Woman
Woman

Our Partners

Our Partners

Impact through deep domain expertise.

Impact through deep domain expertise.

Smile

Aptahem

We are very pleased to announce that Jarlen Capital will be supporting Aptahem in identifying and engaging potential partners for its lead asset, Apta-1. We look forward to working closely with the Aptahem team to advance partnering discussions and support the continued development of Apta-1.

Woman
Smile

Aptahem

We are very pleased to announce that Jarlen Capital will be supporting Aptahem in identifying and engaging potential partners for its lead asset, Apta-1. We look forward to working closely with the Aptahem team to advance partnering discussions and support the continued development of Apta-1.

Smile

Aptahem

We are very pleased to announce that Jarlen Capital will be supporting Aptahem in identifying and engaging potential partners for its lead asset, Apta-1. We look forward to working closely with the Aptahem team to advance partnering discussions and support the continued development of Apta-1.

Woman

We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.

Smile

UV Medico

Through this partnership, we support healthcare providers and high-risk environments with an innovative infection-prevention solution that helps protect patients, staff, and visitors. UV Medico’s approach aligns with our commitment to bringing practical, high-quality technologies to organisations seeking safer, cleaner, and more resilient spaces.

Woman
Smile

UV Medico

Through this partnership, we support healthcare providers and high-risk environments with an innovative infection-prevention solution that helps protect patients, staff, and visitors. UV Medico’s approach aligns with our commitment to bringing practical, high-quality technologies to organisations seeking safer, cleaner, and more resilient spaces.

We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.

Smile

Sanyou Biopharmaceuticals

We’re appointed by Sanyou Biopharmaceuticals to represent its biologics discovery and development services in Europe, giving our biopharma network access to integrated capabilities across antibody discovery, AI-enabled R&D, and CRO/CDO/CPO support. We help accelerate innovative biologics programs with greater efficiency, quality, and confidence.

Woman
Smile

Sanyou Biopharmaceuticals

We’re appointed by Sanyou Biopharmaceuticals to represent its biologics discovery and development services in Europe, giving our biopharma network access to integrated capabilities across antibody discovery, AI-enabled R&D, and CRO/CDO/CPO support. We help accelerate innovative biologics programs with greater efficiency, quality, and confidence.

We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.

How we can help

How we can help

More than a deal advisor, we’re your growth partner.

More than a deal advisor, we’re your growth partner.

Rely on us as your cross-border partner for BioPharma strategy, BD&L, and investor support. We help you refine your development and market strategy, identify and approach the right partners, and shape transaction structures that create long-term value for both innovators and investors.

Kristoffer Danielsson

Founder

Rely on us as your cross-border partner for BioPharma strategy, BD&L, and investor support. We help you refine your development and market strategy, identify and approach the right partners, and shape transaction structures that create long-term value for both innovators and investors.

Kristoffer Danielsson

Founder

Rely on us as your cross-border partner for BioPharma strategy, BD&L, and investor support. We help you refine your development and market strategy, identify and approach the right partners, and shape transaction structures that create long-term value for both innovators and investors.

Kristoffer Danielsson

Founder

Your questions, our expert answers

Your questions, our expert answers

01.

At what stage of development does it make sense to work with Jarlen Capital?

02.

Do you only work with biotech companies, or also with pharma and investors?

03.

How do you typically engage, project-based, ongoing support, or as an extended BD function?

04.

How is your work different from what a bank, broker, or generic consulting firm would do?

At what stage of development does it make sense to work with Jarlen Capital?

Do you only work with biotech companies, or also with pharma and investors?

How do you typically engage, project-based, ongoing support, or as an extended BD function?

How is your work different from what a bank, broker, or generic consulting firm would do?

We always strive for excellence

We connect visionary researchers and impact driven investors to shape the future of healthcare.

We always strive for excellence

We connect visionary researchers and impact driven investors to shape the future of healthcare.

We always strive for excellence

We connect visionary researchers and impact driven investors to shape the future of healthcare.

Logo

Deep domain expertise. Better BioPharma deals

Where Visionaries Shape The Future And Leave a Lasting Legacy

© Jarlen Capital powered by Sphere Corporate